Vivoo pH Test Recalled Due to Lack of Marketing Clearance and Risk of Inaccurate Results
Changchun Wancheng Bio-Electron Co., Ltd. has voluntarily recalled 500 Vivoo pH Test strips because they were distributed without legal marketing clearance, posing a risk of false diagnostic results.
What Happened
Changchun Wancheng Bio-Electron Co., Ltd. has initiated a voluntary recall of its Vivoo pH Test strips. The recall was triggered because the devices, which require 510(k) clearance, were distributed to U.S. customers before they could be legally marketed. According to the FDA, these devices may cause false or inaccurate diagnostic results when used by a layperson, which could lead to inappropriate medical interventions.
Which Products Are Affected
The recall affects the following product:
- Product Name: Vivoo pH Test
- Lot Number: 2024013121
- Expiration Date: 01/30/2026
- Quantity: 500 units
- Recall Number: Z-1264-2026
While distribution is listed as nationwide, specific distribution was confirmed in the states of Texas (TX), Georgia (GA), and California (CA).
What You Should Do
Consumers who have purchased the affected Vivoo pH Test strips should stop using the product immediately. The firm initiated the recall via notification letters. For information regarding returns, refunds, or disposal of the product, consumers should contact the recalling firm, Changchun Wancheng Bio-Electron Co., Ltd., located in Changchun, China.
Why This Matters
Using medical diagnostic tests that have not received proper regulatory clearance poses a safety risk, as inaccurate readings can lead users to seek unnecessary medical treatment or fail to seek necessary care based on faulty data.
Source
Information provided by the FDA.
Source: FDA Official Notice
Related Articles
Philips North America Recalls Spectral CT 7500 on Rails Over Potential Rotor Part Displacement
FDA · February 25, 2026
Medline Industries Recalls Mercy Circumcision Trays Due to Compromised Packaging
FDA · February 25, 2026
Medline Industries Recalls Reprocessed ViewFlex Xtra ICE Catheters Due to Potential Particle Contamination
FDA · February 25, 2026